Diabetes Corporation of America dba DCA Pharmacy recalls Sermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection, Diabetes Corporation of America dba
Recalled October 14, 2015 · FDA recall D-0006-2016 · Diabetes Corporation of America
Hazard
Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility assurance. · FDA Class II
Units
129 vials
Sold at
KY, OH, TN
Description
Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility assurance.
Product
Sermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection, Diabetes Corporation of America dba DCA Pharmacy, Franklin, TN 37064-5527
Manufacturer(s)
Diabetes Corporation of America dba DCA Pharmacy
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →